Organogenesis Holding (ORGO) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Oranogenesis Holdings (ORGO) PT Raised to $3.80 at Cantor Fitzgerald
November 13, 2024 7:16 AM ESTCantor Fitzgerald analyst Ross Osborn raised the price target on Oranogenesis Holdings (NASDAQ: ORGO) to $3.80 (from $3.50) while maintaining a Overweight rating.
The analyst comments "We reiterate our Overweight and increase our 12-month price target to $3.80 from $3.50 on Organogenesis' ("ORGO") shares following the... More
